KINGDON CAPITAL MANAGEMENT, L.L.C. - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 85 filers reported holding ANTARES PHARMA INC in Q2 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
KINGDON CAPITAL MANAGEMENT, L.L.C. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q2 2017$3,049,000
-40.3%
946,987
-47.3%
0.21%
-26.0%
Q1 2017$5,108,000
+8.7%
1,798,495
-10.8%
0.28%
+23.8%
Q4 2016$4,699,000
+71.9%
2,016,830
+24.0%
0.23%
+81.6%
Q3 2016$2,733,000
+103.5%
1,626,738
+27.2%
0.12%
+68.9%
Q2 2016$1,343,000
+17.5%
1,278,868
-2.6%
0.07%
+17.5%
Q1 2016$1,143,000
-53.3%
1,313,248
-35.1%
0.06%
-47.1%
Q4 2015$2,449,000
-26.7%
2,023,868
+3.0%
0.12%
-26.1%
Q3 2015$3,342,000
-3.5%
1,965,738
+18.0%
0.16%
+19.3%
Q2 2015$3,465,000
+9.7%
1,665,738
+42.9%
0.14%
+0.7%
Q1 2015$3,159,000
+5.4%
1,165,7380.0%0.13%
+3.1%
Q4 2014$2,996,000
+40.5%
1,165,7380.0%0.13%
+35.4%
Q3 2014$2,133,000
-31.2%
1,165,7380.0%0.10%
-19.3%
Q2 2014$3,101,000
-40.4%
1,165,738
-21.8%
0.12%
-55.3%
Q1 2014$5,203,000
-35.5%
1,490,738
-17.4%
0.27%
-27.9%
Q4 2013$8,064,000
+245.4%
1,804,100
+213.8%
0.37%
+220.9%
Q3 2013$2,335,000
+13.1%
575,000
+15.0%
0.12%
-5.7%
Q2 2013$2,065,000500,0000.12%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
JW Asset Management, LLC 1,671,956$5,384,0003.43%
ARMISTICE CAPITAL, LLC 5,700,000$18,354,0002.34%
Rubric Capital Management LP 3,188,600$10,267,0002.12%
Broadfin Capital, LLC 4,803,528$15,467,0001.88%
THOMPSON DAVIS & CO., INC. 192,734$621,0001.00%
Asymmetry Capital Management, L.P. 199,655$643,0000.76%
Perceptive Advisors 4,267,253$13,741,0000.69%
KINGDON CAPITAL MANAGEMENT, L.L.C. 946,987$3,049,0000.21%
Brown Advisory Securities, LLC 275,000$886,0000.20%
EAM Investors, LLC 251,619$810,0000.13%
View complete list of ANTARES PHARMA INC shareholders